Related Experiment Video
Updated: Oct 11, 2025

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Future Perspectives of Newborn Screening for Inborn Errors of Immunity
Maartje Blom1, Robbert G M Bredius2, Mirjam van der Burg1
1Laboratory for Pediatric Immunology, Department of Pediatrics, Willem-Alexander Children's Hospital, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
Insights
Newborn screening (NBS) programs are expanding to include more inborn errors of immunity (IEI) beyond severe combined immunodeficiency (SCID). New technologies show promise for early detection of various IEI, but require careful evaluation before widespread adoption.
Area of Science:
- Immunology
- Genetics
- Public Health
Background:
- Newborn screening (NBS) programs have expanded, notably with the T-cell receptor excision circle (TREC) assay for severe combined immunodeficiency (SCID).
- SCID was the first inborn error of immunity (IEI) included in population-based screening, utilizing the first high-throughput DNA-based test in NBS.
Purpose of the Study:
- To explore the potential of new technologies for early detection of various IEI in newborns.
- To identify other IEI that could benefit from early diagnosis and intervention through NBS.
Main Methods:
- Review of technological advancements including KREC analysis, epigenetic immune cell counting, protein profiling, and genomic techniques (NGS, WGS).
- Assessment of the feasibility of integrating these advanced tests into existing NBS programs.
Main Results:
- Current NBS primarily screens for SCID using the TREC assay.
- Emerging technologies like KREC analysis, epigenetic assays, protein profiling, and next-generation sequencing (NGS) offer potential for broader IEI screening.
- Early detection of various IEI can prevent severe infections, immune dysregulation, and autoimmunity.
Conclusions:
- Advances in molecular and genomic technologies present opportunities to expand NBS for a wider range of IEI.
- Further examination of technical, ethical, social, legal, logistical, and cost implications is crucial before incorporating new IEI into NBS programs.
Abstract:
Newborn screening (NBS) programs continue to expand due to innovations in both test methods and treatment options. Since the introduction of the T-cell receptor excision circle (TREC) assay 15 years ago, many countries have adopted screening for severe combined immunodeficiency (SCID) in their NBS program. SCID became the first inborn error of immunity (IEI) in population-based screening and at the same time the TREC assay became the first high-throughput DNA-based test in NBS laboratories. In addition to SCID, there are many other IEI that could benefit from early diagnosis and intervention by preventing severe infections, immune dysregulation, and autoimmunity, if a suitable NBS test was available. Advances in technologies such as KREC analysis, epigenetic immune cell counting, protein profiling, and genomic techniques such as next-generation sequencing (NGS) and whole-genome sequencing (WGS) could allow early detection of various IEI shortly after birth. In the next years, the role of these technical advances as well as ethical, social, and legal implications, logistics and cost will have to be carefully examined before different IEI can be considered as suitable candidates for inclusion in NBS programs.
Related Concept Videos
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Microorganisms in Medicine and Therapeutics
Rh Blood Group
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Inborn Errors of Metabolism

